Differential risk of herpes zoster infection with biologic agent use in rheumatoid arthritis: comment on the article by Yun et al

Arthritis Care Res (Hoboken). 2015 Jul;67(7):1041. doi: 10.1002/acr.22526.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antirheumatic Agents / adverse effects*
  • Arthritis, Rheumatoid / drug therapy*
  • Biological Products / adverse effects*
  • Female
  • Herpes Zoster / epidemiology*
  • Humans
  • Male
  • Opportunistic Infections / epidemiology*

Substances

  • Antirheumatic Agents
  • Biological Products